216 related articles for article (PubMed ID: 16582589)
1. Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis.
Hong S; Pusapati RV; Powers JT; Johnson DG
Cell Cycle; 2006 Apr; 5(8):801-3. PubMed ID: 16582589
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis.
Sluss HK; Gannon H; Coles AH; Shen Q; Eischen CM; Jones SN
Mol Cancer Res; 2010 Feb; 8(2):216-22. PubMed ID: 20145032
[TBL] [Abstract][Full Text] [Related]
3. ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.
Pusapati RV; Rounbehler RJ; Hong S; Powers JT; Yan M; Kiguchi K; McArthur MJ; Wong PK; Johnson DG
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1446-51. PubMed ID: 16432227
[TBL] [Abstract][Full Text] [Related]
4. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
[TBL] [Abstract][Full Text] [Related]
5. E2F1 and E2F3 activate ATM through distinct mechanisms to promote E1A-induced apoptosis.
Hong S; Paulson QX; Johnson DG
Cell Cycle; 2008 Feb; 7(3):391-400. PubMed ID: 18235226
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.
Rogoff HA; Pickering MT; Frame FM; Debatis ME; Sanchez Y; Jones S; Kowalik TF
Mol Cell Biol; 2004 Apr; 24(7):2968-77. PubMed ID: 15024084
[TBL] [Abstract][Full Text] [Related]
7. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
Song H; Hollstein M; Xu Y
Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
[TBL] [Abstract][Full Text] [Related]
8. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.
Mallette FA; Gaumont-Leclerc MF; Ferbeyre G
Genes Dev; 2007 Jan; 21(1):43-8. PubMed ID: 17210786
[TBL] [Abstract][Full Text] [Related]
9. The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.
Reimann M; Loddenkemper C; Rudolph C; Schildhauer I; Teichmann B; Stein H; Schlegelberger B; Dörken B; Schmitt CA
Blood; 2007 Oct; 110(8):2996-3004. PubMed ID: 17562874
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.
Kang J; Ferguson D; Song H; Bassing C; Eckersdorff M; Alt FW; Xu Y
Mol Cell Biol; 2005 Jan; 25(2):661-70. PubMed ID: 15632067
[TBL] [Abstract][Full Text] [Related]
11. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
[TBL] [Abstract][Full Text] [Related]
12. An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus.
E X; Pickering MT; Debatis M; Castillo J; Lagadinos A; Wang S; Lu S; Kowalik TF
PLoS Pathog; 2011 May; 7(5):e1001342. PubMed ID: 21589897
[TBL] [Abstract][Full Text] [Related]
13. p53: guardian of the genome and policeman of the oncogenes.
Efeyan A; Serrano M
Cell Cycle; 2007 May; 6(9):1006-10. PubMed ID: 17457049
[TBL] [Abstract][Full Text] [Related]
14. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
[TBL] [Abstract][Full Text] [Related]
15. A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity.
Kabacik S; Ortega-Molina A; Efeyan A; Finnon P; Bouffler S; Serrano M; Badie C
Cell Cycle; 2011 Apr; 10(7):1152-61. PubMed ID: 21389785
[TBL] [Abstract][Full Text] [Related]
16. Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells.
Brew CT; Aronchik I; Hsu JC; Sheen JH; Dickson RB; Bjeldanes LF; Firestone GL
Int J Cancer; 2006 Feb; 118(4):857-68. PubMed ID: 16152627
[TBL] [Abstract][Full Text] [Related]
17. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D.
Lu X; Nguyen TA; Donehower LA
Cell Cycle; 2005 Aug; 4(8):1060-4. PubMed ID: 15970689
[TBL] [Abstract][Full Text] [Related]
18. ATM is down-regulated by N-Myc-regulated microRNA-421.
Hu H; Du L; Nagabayashi G; Seeger RC; Gatti RA
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1506-11. PubMed ID: 20080624
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppression by p53 in the absence of Atm.
Bailey SL; Gurley KE; Hoon-Kim K; Kelly-Spratt KS; Kemp CJ
Mol Cancer Res; 2008 Jul; 6(7):1185-92. PubMed ID: 18583527
[TBL] [Abstract][Full Text] [Related]
20. The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis.
Li M; Fang X; Baker DJ; Guo L; Gao X; Wei Z; Han S; van Deursen JM; Zhang P
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14188-93. PubMed ID: 20663956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
